Pages that link to "Q36381003"

The following pages link to Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. (Q36381003):

Displaying 32 items.

• Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables (Q26865426) (← links)
• Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine (Q34099243) (← links)
• Novel therapeutic strategies for adult obese asthmatics (Q34295008) (← links)
• Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. (Q34448584) (← links)
• Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy (Q36173994) (← links)
• Cocoa and chocolate in human health and disease (Q36417456) (← links)
• Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial. (Q36845012) (← links)
• Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim (Q36855785) (← links)
• Mitochondrial dysfunction in metabolic syndrome and asthma (Q36942788) (← links)
• Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases (Q37009925) (← links)
• Effects of spinach nitrate on insulin resistance, endothelial dysfunction markers and inflammation in mice with high-fat and high-fructose consumption (Q37247258) (← links)
• Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. (Q37365823) (← links)
• Cellular ADMA: regulation and action (Q37399711) (← links)
• Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp (Q37403981) (← links)
• The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. (Q37860140) (← links)
• The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes (Q37963876) (← links)
• Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease (Q37980497) (← links)
• Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? (Q41205365) (← links)
• Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. (Q42078341) (← links)
• Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome (Q44130303) (← links)
• Use of dark chocolate for diabetic patients: a review of the literature and current evidence (Q44993864) (← links)
• Transcriptional changes in mesenteric and subcutaneous adipose tissue from Holstein cows in response to plane of dietary energy (Q47137849) (← links)
• Role of nitric oxide synthase gene intron 4 and exon 7 polymorphisms in obstructive sleep apnea syndrome (Q48428510) (← links)
• Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle (Q49202628) (← links)
• Transcriptional control of human adipose tissue blood flow (Q51433131) (← links)
• Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women. (Q54531644) (← links)
• Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients (Q57062959) (← links)
• PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice (Q58699564) (← links)
• Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients (Q80687445) (← links)
• Effects of Eicosapentaenoic Acid on Asymmetric Dimethylarginine in Patients in the Chronic Phase of Cerebral Infarction: A Preliminary Study (Q83322507) (← links)
• Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients (Q85523404) (← links)
• Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction from Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice through Regulating the PI3K/AKT/GSK-3β and Bcl-2/Bax Signaling Pathways (Q97883932) (← links)